Clariant has completed the sale of its Venezuelan legal entity to CMV Química for about $1.8 million as part of footprint optimisation.
The exit will trigger a non-cash CHF 236 million (~$297.56 million) cumulative translation adjustment, reducing reported net profit and EPS in 2025, but with no impact on cash flow, shareholder distribution policy or EBITDA guidance of 17–18 per cent.
The exit will trigger a non-cash CHF 236 million (~$297.56 million) cumulative translation adjustment, reducing reported net profit and EPS in 2025, but with no impact on cash flow, shareholder distribution policy or EBITDA guidance of 17–18 per cent.
